Alliance Pharma (APH)

 

APH Share PerformanceMore

52 week high55.41 21/03/16
52 week low40.50 27/06/16
52 week change 0.38 (0.77%)
4 week volume8,516,997 28/01/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Director Deals - Alliance Pharma PLC (APH)

Peter Butterfield, Executive Director, exercised 90,222 shares in the company on the 14th February 2017 at a price of 33.25p...

Director Deals - Alliance Pharma PLC (APH)

Peter Butterfield, Executive Director, sold post-exercise 61,846 shares in the company on the 14th February 2017 at a price of...

PDMR shareholding

RNS Number: 8887W Alliance Pharma PLC 14 February 2017 For immediate release 14 February 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") PDMR shareholding Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that Peter Butterfield, a director of the Company and its Deputy CEO has today exercised an opti...

Application for admission

RNS Number: 8886W Alliance Pharma PLC 14 February 2017 For immediate release 14 February 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Application for admission Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that following the exercise of employee share options, application has been made by Allianc...

Changes to interests of a significant shareholder

RNS Number: 2184W Alliance Pharma PLC 07 February 2017 For immediate release 7 February 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Changes to interests of a significant shareholder Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, has received a notification of a change in the interests of a significant shareholder...

Exercise of Share Options

RNS Number: 5550V Alliance Pharma PLC 31 January 2017 For immediate release 31January 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Exercise of Share Options Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that following the exercise of employee share options, application has been made by Alliance for...

Hardman Research: Potential of Diclectin

RNS Number: 0190V Alliance Pharma PLC 25 January 2017 Hardman Research: Potential of Diclectin Potential of Diclectin: Alliance Pharma's buy-and-build strategy to evolve into a profitable, cash generative, specialty pharma business is clearly bearing fruit. Acquisition of the dermatology and woundcare products from Sinclair Pharma was transformational, dou...

Alliance revenues more than double

Alliance Pharma said it expected revenue for the year ended 31 December to be more than double the prior year at 97.5m (...

Fundamental DataMore

P/E ratio10.538
EPS4.65
Dividend yield2.245 %

Equity Research (APH)

Alliance Pharma plc
01/02/2017
Early Equity (EEQP.NEX) 1.1p £7m FY Aug 16 results from the UK investment Company that provides equity and debt capital, along with strategic and operational counsel, to businesses that have the...
hardman & co
Alliance Pharma plc
25/01/2017
Alliance Pharma’s buy-and-build strategy to evolve into a profitable, cash generative, specialty pharma business is clearly bearing fruit. Acquisition of the dermatology and woundcare products from...
hardman & co
Alliance Pharma plc
07/06/2016
Alliance Pharma has adopted a buy-and-build strategy to evolve through a series of 28 acquisitions into a profitable, cash generative, specialty pharma business. The acquisition of part of the...

Latest discussion posts More

  • Re: 'Screeming Buy'.says M.F.

    Share price currently favourably low, making APH even mere of a screeming buy than before, IMO. In my view, the shares are worth in region of 55p to 60p, based on earnings ...
    21-Nov-2016
    winningstreak
  • Re: 3m shares

    Like anyone else, even CEO's may wish to upgrade their private lives,, their house, their kids' schooling etc. A nagging wife often sees to that. Meantime, here, he ...
    23-Sep-2016
    winningstreak
  • Re: 3m shares

    This does not exactly fill the investors and potential investors with a confidence. nk
    23-Sep-2016
    nk1999

Users' HoldingsMore

Users who hold Alliance Pharma also hold..
LLOYDS GRP.26%
BP19%
NATIONAL GRID16%
GLAXOSMITHKLINE15%
TESCO14%

Codes & Symbols

ISINGB0031030819
SymbolsAPH, LSE:APH, APH.L, APH:LN, LON:APH, XLON:APH